BOS-475

DRUG2 trials

Sponsors

Boston Pharmaceuticals

Conditions

Chronic Plaque PsoriasisPsoriasis

Phase 1

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis

CompletedNCT03960450

Boston PharmaceuticalsPsoriasis

Start: 2019-04-23End: 2020-01-28Updated: 2020-11-18

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

CompletedNCT04221906

Boston PharmaceuticalsChronic Plaque Psoriasis

Start: 2020-01-06End: 2020-03-06Updated: 2020-11-18